Nature Communications (Aug 2023)

C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption

  • Abhishek Bharadwaj Sharma,
  • Muhammad Khairul Ramlee,
  • Joel Kosmin,
  • Martin R. Higgs,
  • Amy Wolstenholme,
  • George E. Ronson,
  • Dylan Jones,
  • Daniel Ebner,
  • Noor Shamkhi,
  • David Sims,
  • Paul W. G. Wijnhoven,
  • Josep V. Forment,
  • Ian Gibbs-Seymour,
  • Nicholas D. Lakin

DOI
https://doi.org/10.1038/s41467-023-40779-9
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 15

Abstract

Read online

Abstract While the toxicity of PARP inhibitors to cells with defects in homologous recombination (HR) is well established, other synthetic lethal interactions with PARP1/PARP2 disruption are poorly defined. To inform on these mechanisms we conducted a genome-wide screen for genes that are synthetic lethal with PARP1/2 gene disruption and identified C16orf72/HAPSTR1/TAPR1 as a novel modulator of replication-associated R-loops. C16orf72 is critical to facilitate replication fork restart, suppress DNA damage and maintain genome stability in response to replication stress. Importantly, C16orf72 and PARP1/2 function in parallel pathways to suppress DNA:RNA hybrids that accumulate at stalled replication forks. Mechanistically, this is achieved through an interaction of C16orf72 with BRCA1 and the RNA/DNA helicase Senataxin to facilitate their recruitment to RNA:DNA hybrids and confer resistance to PARP inhibitors. Together, this identifies a C16orf72/Senataxin/BRCA1-dependent pathway to suppress replication-associated R-loop accumulation, maintain genome stability and confer resistance to PARP inhibitors.